From: Synergies in exosomes and autophagy pathways for cellular homeostasis and metastasis of tumor cells
Cancer type | Exosomal proteins as biomarker | Autophagic proteins as biomarker |
---|---|---|
Bladder | α6-integrin, Basigin, TACSTD2, Mucin4, EDIL-3, EPS8L2, MUC-1 [169] | NR |
Breast | Survivin, Survivin-2B, CEA, Tumor antigen15-3 [170] | LC3β [171], LC3α [172], ULK-1 [173], Beclin-1 [174], FIP200 [175] |
Cervical | ATF1, RAS [176] | NR |
Colorectal | CEA [110] | Beclin1, LC3β [174] |
Gastric | NR | ULK1, Beclin 1, ATG3, ATG10 [161] |
GBM | EGFRvIII [177] | NR |
Melanoma | CD63, Caveolin1, TYRP2, VLA-4, HSP70 [110] | LC3β [178] |
lung | EpCAM, EGFR, CEA, LRG-1 [179] | |
Ovarian | MAGE3/6, Claudin-4, L1CAM, TGFβ1, CD24, ADAM10, EMMPRIN [181] | NR |
Pancreatic | GPC1, MIF [182] | NR |
Prostate | Survivin, PTEN, Transmembranes, Protease, ITGB1, Serine2-ETS, β-catenin, PSA, PCA3, PSMA, ITGA3 [183] | NR |